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Abstract
Background: Community advisory boards (CABs) have expanded beyond high-income countries (HICs) and play an
increasing role in low- and middle-income country (LMIC) research. Much research has examined CABs in HICs, but
less is known about CABs in LMICs. The purposes of this scoping review are to examine the creation and
implementation of CABs in LMICs, including identifying frequently reported challenges, and to discuss implications
for research ethics.
Methods: We searched five databases (PubMed, Embase, Global Health, Scopus, and Google Scholar) for
publications describing or evaluating CABs in LMICs. Two researchers independently reviewed articles for inclusion.
Data related to the following aspects of CABs were extracted from included publications: time, country, financial
support, research focus, responsibilities, and challenges. Thematic analyses were used to summarize textual data
describing challenges.
Results: Our search yielded 2005 citations, 83 of which were deemed eligible for inclusion. Most studies (65) were
published between 2010 and 2017. Upper-middle-income countries were more likely to have studies describing CABs,
with South Africa (17), China (8), and Thailand (7) having the greatest numbers. The United States National Institutes of
Health was the main source of financial support for CABs. Many CABs (53/88, 60%) focused on HIV research. Thirty-four
studies reported how CABs influenced the informed consent process for clinical trials or other aspects of research
ethics. CAB responsibilities were related to clinical trials, including reviewing study protocols, educating local
communities about research activities, and promoting the ethical conduct of research. Challenges faced by CABs
included the following: incomplete ethical regulations and guidance; limited knowledge of science among members
of communities and CABs; unstable and unbalanced power relationships between researchers and local communities;
poor CAB management, including lack of formal participation structures and absence of CAB leadership; competing
demands for time that limited participation in CAB activities; and language barriers between research staff and
community members. Several challenges reflected shortcomings within the research team.
Conclusions: Our findings examine the formation and implementation of CABs in LMICs and identify several ethical
challenges. These findings suggest the need for further ethics training among CAB members and researchers in LMICs.
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Background
Organizing research studies in low- and middle-income
countries (LMICs) present a number of challenges, in-
cluding difficulties in ensuring community consultation
[1–3]. Many funders now require that clinical trials en-
gage with participating communities [4–6]. Community
engagement is the process of working collaboratively
with relevant stakeholders to address health-related is-
sues that concern them [7, 8]. Community engagement
can empower communities by actively soliciting input
from potential research subjects, involving them in deci-
sion making, and ensuring their perspectives, attitudes,
and values are respected [9]. Moreover, community en-
gagement can build community trust in research, facili-
tate participant enrollment, and assist in post-trial
implementation [4, 6, 8, 10].
Community advisory boards (CABs) are a well-
established form of community engagement to strengthen
research ethics [8, 11, 12]. The United States (US) Na-
tional Institutes of Health (NIH) officially mandated CAB
inclusion in all HIV clinical trials in 1987 [13]. CABs are
typically composed of diverse individuals selected to rep-
resent researched communities [14]. Through organizing
activities such as community consultations and regular
feedback meetings, CABs provide trial participants and
potential participants with an opportunity to understand
the research process and voice concerns [15]. CABs also
advocate for trial participants and promote the ethical
conduct of research [14, 15].
Over the past three decades, CABs have become a
standard mechanism for community engagement in
HIV clinical trials conducted in high-income countries
(HICs) [14, 16–18]. With the growth of the global NIH
HIV trials network [19–22], CABs are increasingly
formed in LMICs [14, 21]. While much research has
examined CABs in HICs [16, 22, 23], these findings
may be less relevant in LMIC settings. A growing litera-
ture has described CABs in LMICs over the past decade
[16, 17, 24–26]. CABs in LMICs operate in environ-
ments that are distinct from their HIC counterparts. A
range of economic, cultural, social, and historical con-
siderations may constrain CABs in LMICs. The pur-
poses of this scoping review are to provide an overview
of the published literature describing the formation, im-
plementation, and frequently reported challenges of
CABs in LMICs, and to discuss implications for re-
search ethics.
Methods
Identifying the research question and relevant studies
This scoping review followed the methodological frame-
work for conducting a scoping study proposed by Arksey
and O’Malley [27]. We first defined the objectives of our
scoping review as providing an overview of the published
literature describing the formation and implementation
of CABs in LMICs, including relevant challenges faced
by CABs in LMICs, and discussing implications for re-
search ethics. We then identified relevant studies
through an online search. Five databases were searched
(PubMed, Embase, Global Health, Scopus, and Google
Scholar) for English-language entries examining CABs in
LMICs published before 01 December 2017. Search
terms included “community advisory*” OR “community
advisory board*” OR “community advisory group*” OR
“community steering committee*” OR “community con-
stituency group*” OR “community collaborative board*”
OR “community working group*”.
Selecting studies for inclusion
Two reviewers (YZ, BW) independently screened titles
and abstracts for inclusion. Titles and abstracts focusing
on CABs in HICs were excluded. Disagreement about
inclusion or exclusion of abstracts was discussed and re-
solved by consensus between the same two reviewers.
Full-text publications were then screened by two re-
viewers (YZ, BW) who ensured all articles included de-
scriptions of the formation or implementation of a CAB,
discussions of the challenges involved in operating a
CAB, or explorations of the possibility of organizing a
CAB in an LMIC. Studies only referring to a CAB with-
out mentioning related characteristics or in-depth
discussion were excluded. Included publications were
peer-reviewed articles, book chapters, and detailed sum-
maries of research presented at international confer-
ences. Our scoping review primarily focused on the
peer-reviewed full articles, but other publications, in-
cluding abstracts, were also included to supplement
findings and present a more comprehensive overview of
CABs in LMICs. The process of study selection is out-
lined in Fig. 1.
Charting the data
Data related to the following aspects of CABs were ex-
tracted from all publications selected for inclusion: year
of publication, country or region in which the CAB was
operated, membership, activities, funding sources, re-
search focus, achievements, and challenges. Thematic
analyses were conducted to summarize and categorize
extracted data.
Results
Our initial search identified 2005 potentially relevant
publications. After screening titles, abstracts, and full-
text manuscripts, 83 publications met selection criteria
and were included in our analysis. Sixty-three were peer-
reviewed articles, fifteen were international research
conference abstracts, three were presentations from
international research conferences, and two were book
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chapters. Two articles published in Chinese with online
English abstracts were included as abstracts in our ana-
lyses. All abstracts and presentations included a year of
publication and country or region, most described a re-
search focus, and only a few presented specific chal-
lenges. Twenty publications specifically researched a
CAB in an LMIC using a qualitative approach. The
remaining 63 publications described the function of a
CAB in the context of a larger research project.
Year of publication for included publications ranged
from 1976 to 2017. Of the 83 included publications, 78%
(65) were published after 2009, and 52% (43) were pub-
lished within the last 4 years (Fig. 2). Only one study
was published prior to 2000. The 1976 publication
Fig. 1 Selection of included studies
Fig. 2 Number of included publications describing CABs in LMICs by year
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proposed establishing a CAB to improve the health of
rural residents in Thailand [28].
The included publications described 88 different CABs
across 26 LMICs and nine geographic regions in Africa,
Asia, Oceania, South America, and Europe. The five
LMICs with the most CABs were South Africa (17), China
(8), Thailand (7), Zimbabwe (6), and India (5). CABs in Af-
rica (n = 49, 56%) and Asia (n = 24, 27%) were dispropor-
tionately represented among 88 CABs described in the
included publications. Only four CABs were based in
South America. Nine studies did not focus on a specific
country, but rather a broader geographic region or eco-
nomic setting (e.g., West Africa, Pacific Islands). Addition-
ally, CABs in LMICs were unevenly distributed across
countries in terms of income level. CABs were dispropor-
tionately represented in upper-middle-income countries,
particularly South Africa, China, and Thailand. In total,
thirty-nine CABs in upper-middle-income countries were
described, accounting for nearly half of all the CABs identi-
fied in this review. In comparison, only 20 and 19 CABs
were in lower-middle-income and low-income countries,
respectively.
We found 41 included publications provided details on
CAB membership and 24 on the process of CAB mem-
bership selection. Members were selected through elec-
tions by community members [26], purposive sampling
selections by the research team, community members,
and sometimes stakeholders [13, 18, 23–25, 29–37], or
mixed methods combining several of these strategies
[16, 24]. A common theme in the descriptions of CAB
formation was promoting diversity in CAB membership
to ensure adequate representation from key groups. We
identified gender, age, religion, class, ethnicity, and reli-
gious affiliation as the most commonly used selection
factors used to promote diversity in CAB membership.
Additionally, CABs also proactively included members
from stakeholder groups specific to certain LMIC con-
texts, such as religious leaders [16, 18, 19, 35, 38–40],
traditional healers [16, 18], individuals from different vil-
lages, cities, and countries [17, 18], media representatives
[39], non-governmental organizations workers [31, 41],
local politicians [42], patients and family members [19,
43–45], refugees [46], and groups at increased risk of
HIV infection (e.g., sex workers, men who have sex with
men, and miners) [16, 19, 41, 47].
CAB activities included training sessions, periodic
meetings, focus group discussions, site visits, conference
calls, and group emails. Ten articles described training
sessions for CAB members, including technical medical
expertise trainings, CAB and community leadership
skills improvement sessions, protocol specific training,
report writing guidance, and protection of research par-
ticipants, which typically lasted several days and were
uniformly conducted before CABs began operating in
their advisory capacity [13, 18, 26, 33]. Most CAB mem-
bers had no formal medical or public health training,
and consequently organizing teams (e.g. research teams,
staff from professional training institutions, and univer-
sities) tended to focus training on improving members’
medical knowledge as well as addressing research goals
and ethics [13, 18, 33, 38, 45, 48, 49]. Once formed, most
CABs held periodic meetings, with meeting frequently
ranging from weekly to monthly to quarterly to yearly.
Meetings typically focused on reporting and discussing
progress in preparing, designing or implementing clin-
ical trials (e.g. updates on study findings and current
ethical challenges). Thirty-four studies reported how
CABs influenced clinical trial informed consent or
other aspects of research ethics. CAB activities also
included educating communities about research activ-
ities and facilitating qualitative research related to on-
going clinical trials.
Most CABs in LMICs were supported through funding
from the NIH or other research institutions based in
HICs. Among the 34 CABs whose funding sources were
reported, 41% (14) were part of projects that were entirely
funded by the NIH. Seven CABs were part of projects that
were funded by European institutions, including the Well-
come Trust (4), National Belgian Lottery Fund (1), and
German Federal Ministry of Education and Research (1).
Eleven CABs received financial support by being part of
projects from both domestic and foreign sources. For ex-
ample, a CAB in Tanzania was part of a project that was
funded by the Ifakara Health Institute with support from
both Switzerland and Tanzania, and a CAB in India re-
ceived funding by being part of a project from the Indian
Council of Medical Research and the NIH [37]. Only one
CAB located in South Africa received funding exclusively
from domestic sources.
Most CABs (53 publications, 60%) in our sample ad-
vised on HIV research [50–60], vaginal microbicides
[61, 62], and antiretroviral medication adherence [37].
Seven CABs advised on research related to other in-
fectious diseases, including tuberculosis [17, 18] and
malaria [38, 63]. Eight CABs focused on research for
non-infectious diseases, including stroke, cancer, mal-
nutrition, and mental illness [30, 35, 39, 64–69]. 19
CABs did not address a specific disease and instead
focused on healthcare delivery and public health cam-
paigns generally, including rural and primary health-
care services [46, 70–77]. Finally, one CAB advised on
non-medical research, namely, earthquake prepared-
ness [78]. CAB research foci are presented in Fig. 3.
Fourteen of the included publications provided de-
tailed descriptions of CAB achievements. According to
these descriptions, CABs in LMICs improved recruit-
ment strategies, enhanced relationships between re-
searchers and local communities, and addressed ethical
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concerns related to participant risk in collaboration with
institutional review boards (IRBs). For example, the CAB
in a South African schizophrenia genomics study helped
individual research participants decide about data shar-
ing [25]. Some researchers may lack specialized know-
ledge of specific locations and sub-cultures within a
diverse region [64]. As part of the community, CABs
were often presented as a ‘bridge,’ ‘belt,’ ‘link,’ or ‘inter-
mediary’ that helped to solidify partnerships between re-
searchers and community members [13, 16]. CABs were
described as an efficient tool to ensure that CAB and
community members understood the goals of clinical
trials by providing detailed explanations and facilitating
discussions [35, 79]. Informed consent forms were
identified as complex, legalistic, and difficult to under-
stand for vulnerable populations in LMIC settings.
CABs addressed concerns with informed consent lan-
guage [79]. CABs also contributed to study recruitment
by refining recruitment strategies and protecting re-
search participants and the wider community from
research-related risk [25].
Challenges faced by CABs in LMICs were specifically
addressed by 62% (39) of the 63 included articles and
35% (7) of the included abstracts and presentations.
After performing thematic analysis of reported chal-
lenges, we categorized challenges facing CABs in LMICs
into six main types: (1) incomplete ethical regulations
and guidance, (2) limited knowledge of science, (3) com-
peting demands, (4) unbalanced power relations, (5)
poor CAB management, and (6) language barriers.
Incomplete ethical regulations and guidance
Thirteen publications highlighted the absence of guidance
on ethical regulations as having negatively impacted the
work of CABs in LMICs [5, 16, 24, 31, 46, 79–86]. Incom-
plete ethical regulations may engender harm or result in
exploitation of participating communities, particularly in
LMICs where populations are often disadvantaged, mar-
ginalized, or under-resourced. Because of the possibilities
of exploitation and unfair benefits in conducting research
mentioned by the members of CABs in HIV vaccine trials
in South Africa, CAB members and researchers in certain
situations felt unprepared to address the tension between
generating new knowledge and protecting participants
from harm [24]. Essential components of the ethical con-
duct of clinical research were sometimes unclear to CAB
members. For example, CAB members felt uncertain how
to ethically enroll minors in sexual and reproductive
health research studies, particularly those in early child
marriages whose parents did not have parental custody
and control [82]. Consequently, CABs may have been un-
able to adequately perform their function of protecting
local participants in research [16, 82, 83]. Given larger
power imbalances between CABs in LMICs and re-
searchers from HICs, CAB members at these sites pointed
out the need for research projects to leave behind a lasting
benefit for their communities [16].
Limited knowledge of science
Twenty-three publications highlighted knowledge gaps
between researchers and members of communities and
CABs [5, 13, 16, 17, 25, 26, 31–37, 40, 41, 44, 79–81, 84, 85,
87, 88]. It was noted that average members of the popula-
tion in LMICs, including CAB members, were more likely
to have lower levels of education compared to HICs [5, 35].
Consequently, authors expressed concerns about CAB
members not fully comprehending the nature of the study
and concepts being researched [13, 16, 17, 32, 40, 87, 88].
Since members of communities and CABs had different
levels of education and social backgrounds compared to
researchers, they may not have fully understood or appreci-
ated researchers’ viewpoints, and researchers may have
lacked the cross-cultural knowledge and skills necessary
to make this knowledge accessible to local communities
Fig. 3 CAB research foci in LMICs
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[13, 17, 25, 31, 87]. For instance, CAB members at one
institution were at times unable to explain detailed
research procedures to inform communities. This was
not only due to the limited science knowledge of par-
ticipating communities, but also related to the lack of
cross-cultural understanding and skills on the part of
researchers [33]. Inadequate consideration of commu-
nity perspectives on the part of research teams has con-
tributed to miscommunication in many research
studies [31].
Unstable and unbalanced power relations
Unstable and unbalanced power relations among CAB
members and between CAB members and researchers
were identified in 18 publications [5, 18, 24, 26, 31, 33,
35, 36, 38, 45, 57, 63, 64, 81, 87, 89–91]. CAB members
were sometimes less likely to challenge the opinions of
doctors and researchers because of internalized percep-
tions that it was inappropriate to question those in posi-
tions of authority [5]. Political tensions were specifically
identified as impacting CAB operations in China [89],
South Africa [24], and along the Thai-Myanmar border
[5, 38, 63]. The diversity of religious, political, language,
and ethnic groups along the Thai-Myanmar border
raised questions as to what constituted a community
and who may serve as a community representative.
Moreover, due to incomplete CAB membership selection
criteria [87], marginalized groups tended to be over-
looked during CAB formation. For instance, the electoral
model used to establish CABs at the HIV vaccine trial
sites in South Africa was not purely democratic, as they
elected one person to represent all the 50 families during
an ad hoc meeting [24]. The selection of CAB represen-
tatives was not always democratic. One CAB was com-
posed of individuals selected only by chiefs or health
care workers [33]. The membership and participation of
some women in a South African CAB were limited due
to the impact gender-based violence on the selection
process [29, 87]. Few CABs used an electoral model to
select members, and many CABs lacked a formal struc-
ture for participation [5, 33]. These complex and politic-
ally sensitive issues were difficult for CAB organizers to
resolve [45]. Efforts to implement CAB activities among
target populations were impeded by social hierarchies
due to age, gender, experience, and social status in sev-
eral contexts [5, 31, 57, 91].
Poor CAB management
Poor CAB management was discussed as a challenge in
fourteen publications [5, 13, 17, 18, 24, 26, 29, 33, 34, 38,
81, 85, 87, 92]. Some researchers were inadequate in pro-
viding targeted and appropriate trainings for CAB mem-
bers [17, 26, 34, 81, 85]. Due to poor training, some CAB
members may not have developed the skills necessary to
provide feedback to researchers and liaise with their peers.
For example, some research teams acknowledged that in
the beginning of their clinical trial they did not engage
with the CABs in Malawi, invite them to meetings, or
provide them with the necessary background information
on the clinical trial [26]. Consequently, the broader com-
munity may not have appreciated the value of CAB
engagement [13, 17]. Additionally, several CABs lacked
leadership structures, which negatively impacted CAB
functionality [13, 33]. Some CABs were also required to
work on several research projects simultaneously, poten-
tially affecting members’ ability to sufficiently focus on
particular research issues [18, 38].
Competing demands
Thirteen publications reported that CAB attendance was
negatively affected by other competing demands [5, 13,
16, 17, 26, 32, 33, 35, 37, 41, 64, 81, 85]. Professional
and social obligations, including employment, business
dealings, and social activities [33], prevented members
from consistently participating in CAB meetings and
activities. The demands of full-time employment were
specifically identified as being a challenge for CABs in
four publications [13, 33, 35, 81]. For example, compet-
ing work demands limited the number of participants
who voted at one CAB [33]. Limited economic resources
and insufficient compensation for CAB participation
were identified as a cause of CAB member dissatisfaction
in several included publications [17, 33, 85]. For ex-
ample, community leaders in five studies reported diffi-
culty convincing CAB members to regularly attend CAB
meetings because of insufficient participation incentives
[16, 26, 37, 41, 64]. However, there was also disagree-
ment as to whether participation in CABs should be
driven by financial incentives or a sense of volunteerism
that was primarily motivated by altruism [13].
Language barriers
Language barriers were identified as a challenge in
eleven publications [5, 35, 36, 38–40, 85, 91, 93–95].
CAB members sometimes had low literacy levels and
could not sign their name or read documents related to
research projects [5, 40]. Multiple languages and dialects
were spoken across or within several of the communities
in which CABs were based, creating challenges for
communication between researchers and CAB members
[35, 38, 39, 91]. English proficiency was uncommon
among CAB members in LMICs [35, 36, 85], and in cer-
tain situations the number of translators was insufficient
[93], which further hindered communication. Re-
searchers also tended to have limited abilities in speak-
ing local languages or dialects, although few articles
discussed this limitation in detail. One CAB along the
Thai-Myanmar had twelve of the fourteen founding
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members unable to speak proficient English, and re-
searchers could not understand the diverse local lan-
guages and dialects, which made communication
between researchers and the CAB challenging [5],
Discussion
This scoping review examines the formation, operation,
and challenges of CABs in LMICs and discusses implica-
tions for research ethics. Many CABs have focused on
HIV clinical trials in upper-middle income countries.
Some studies described how CABs influenced the in-
formed consent process and helped address ethical con-
cerns in clinical trials. Several challenges in implementing
CABs in LMICs were identified, particularly challenges re-
lated to ethics guidance and regulations.
Most of the CABs in LMICs described in the included
publications focused on HIV. This may be due to the
growth of the global NIH HIV trials network in LMICs
and HIV trials being more likely to publish on CAB-
related experiences. In contrast, CABs in HICs have ad-
vised on more diverse clinical trials [96–104], ranging
from cardiovascular disease to mental health. This dif-
ference in breadth of research foci may be due to the
fact that the majority of NIH-funded trials in LMICs
have investigated HIV. As the number of chronic dis-
ease trials increase in LMICs [105, 106], CABs may be
able to expand as well. Some CABs originally focused
on HIV have already transitioned to include chronic
diseases [25, 30, 35, 39, 64, 107].
We found that most CABs described in the existing
literature were based in upper-middle-income countries.
Only 19 of the CABs included in this review were based
in low-income countries. This finding is consistent with
prior reviews which found that few studies have investi-
gated community engagement in low-income countries
[8, 108, 109]. Because clinical trials are often conducted
in low-income countries [110–112], future investigations
of CABs should focus on the accomplishments and chal-
lenges specific to this context.
Limited knowledge of science among members of
communities and CABs was a common challenge noted
among CABs in LMICs. Most included publications at-
tributed this challenge to the different levels of educa-
tion and social backgrounds and experience between
researchers and members of communities and CABs.
Eighteen publications mentioned that community mem-
bers had better knowledge of local cultural and social
contexts compared to researchers [5, 12, 13, 24, 25, 28,
29, 31, 36, 39, 43, 48, 50, 57, 62–64, 84]. Eleven publica-
tions also discussed community perceptions of the limi-
tations of researcher-community connections in LMICs
related to knowledge gaps and failure to provide enough
training in science [13, 16, 17, 24, 31, 33, 35, 40, 85, 88,
95]. It is worth noting that researchers may also have
lacked the skills necessary to communicate scientific
knowledge in understandable and meaningful ways to
participating communities. CAB training helped to
build capacity and knowledge among members and re-
searchers [113, 114]. This also suggests the need for
further CAB member and researcher training [16]. Lim-
ited knowledge of science was closely connected with
language barriers, another challenges that exposed the
limitations on the parts of both CAB members and
researchers.
Our data suggest that CAB members sometimes had in-
sufficient ethics guidance. Some researchers were inad-
equate in providing targeted and appropriate trainings for
CAB members [17, 26, 34, 81, 85], and only seven publica-
tions mentioned CAB members had received training on
ethics [13, 18, 33, 38, 45, 48, 49]. Thirteen publications
highlighted the absence of guidance on ethical regulations
of CABs in LMICs and suggested the importance of ethics
training [5, 16, 24, 31, 46, 79–86]. Several ethics guidance
documents related to HIV research have been developed
[115–117]. However, our review suggests these documents
have not been widely incorporated into standard CAB
operations in LMICs. Future research in LMICs should
consider incorporating pre-existing ethics documents, in-
cluding ethics guidelines, statements of shared principles,
and other contextualized ethics documents, into CAB
member training so that CABs are better prepared to ad-
dress ethical concerns.
Our study has several limitations. First, we identified
challenges facing CABs in LMICs based on published lit-
erature, largely reflecting the perspective of research
teams. There are fewer perspectives from communities
themselves in the literature and our review is less able to
capture these important perspectives. Second, our search
was limited to English language publications. English is
not the primary language in many LMICs, and we may
have missed studies in local languages. In addition, the
failure to search through Spanish and French language
publications may have biased our sample. There may
additional relevant publications written in local lan-
guages highlighting the challenges we did not identify in
this review. Third, we included all types of publications,
including peer-reviewed articles, international research
conference abstracts and presentations. While this re-
view primarily based its analysis on data extracted from
peer-reviewed articles, we also included abstracts and
presentations to reinforce and complement our findings.
The different levels of information richness across publi-
cations may mean that some CAB characteristics were
only reported by a subset of studies. Finally, this was not
a systematic review. Inferences about CABs in other set-
tings should be made with caution.
Our findings have implications for LMIC research
ethics. First, CABs allow an opportunity to consider
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research ethics prior to formal IRB review [118]. CABs en-
gage diverse community members and may facilitate de-
liberations about ethical concerns from the community
which can improve the quality of research and pre-empt
issues that may later be identified during formal IRB re-
view [119]. Research ethics goes beyond IRB approval
alone and CABs can help to broaden discussions about re-
search ethics in communities [120]. Second, only some
studies reported the extent to which CABs advising a clin-
ical trial influenced informed consent and research ethics.
This suggests the need for further research about how
CAB activities impact, or fail to impact, the conduct of
clinical trials. Third, our data suggest that capacity
building is needed among both CABs in LMICs and re-
searchers. Training for CAB members to clarify ethics
regulations and theory may be useful. Researchers may
also require additional training to better appreciate the
importance of community engagement, improve com-
munication skills, and potentially learn local languages
or dialects used in participating communities. Finally,
challenges arising from the local contexts were fre-
quently reported in our included articles. Issues specific
to LMIC contexts, such as the high prevalence of child
marriage, should be fully understood and taken into
consideration when CABs and researchers work to-
gether to address ethical challenges.
Conclusions
CABs may be a useful tool for increasing community en-
gagement and the ethical conduct of research in LMICs.
This scoping review describes the implementation and
operations of CABs in LMICs, including challenges faced
by these organizations, and discusses the implications
for research ethics. We found several shortcomings and
opportunities for increasing CAB understanding of re-
search ethics. These findings can help inform training
and related activities to enhance CABs in LMICs.
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